L
L. Joseph Wheat
Researcher at AmeriCorps VISTA
Publications - 162
Citations - 9793
L. Joseph Wheat is an academic researcher from AmeriCorps VISTA. The author has contributed to research in topics: Histoplasmosis & Histoplasma. The author has an hindex of 50, co-authored 161 publications receiving 8260 citations. Previous affiliations of L. Joseph Wheat include Wishard Memorial Hospital & Veterans Health Administration.
Papers
More filters
Journal ArticleDOI
Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium
J. Peter Donnelly,Sharon C.-A. Chen,Carol A. Kauffman,William J. Steinbach,John W. Baddley,Paul E. Verweij,Cornelius J. Clancy,John R. Wingard,Shawn R. Lockhart,Andreas H. Groll,Tania C. Sorrell,Matteo Bassetti,Hamdi Akan,Barbara D. Alexander,David R. Andes,Elie Azoulay,Ralf Bialek,Robert W. Bradsher,Stéphane Bretagne,Thierry Calandra,Angela M. Caliendo,Elio Castagnola,Mario Cruciani,Manuel Cuenca-Estrella,Catherine F. Decker,Sujal R. Desai,Brian T. Fisher,Thomas S. Harrison,Claus Peter Heussel,Henrik Jeldtoft Jensen,Christopher C. Kibbler,Dimitrios P. Kontoyiannis,Bart Jan Kullberg,Katrien Lagrou,Frédéric Lamoth,Thomas Lehrnbecher,J. Loeffler,Olivier Lortholary,Johan Maertens,O. Marchetti,Kieren A. Marr,Henry Masur,Jacques F. Meis,C. Orla Morrisey,Marcio Nucci,Luis Ostrosky-Zeichner,Livio Pagano,Thomas F. Patterson,John R. Perfect,Zdenek Racil,Emmanuel Roilides,Marcus Ruhnke,Cornelia Schaefer Prokop,Shmuel Shoham,Monica A. Slavin,David A. Stevens,George Richard Thompson,Jose A. Vazquez,Claudio Viscoli,Thomas J. Walsh,Adilia Warris,L. Joseph Wheat,P. Lewis White,Theoklis E. Zaoutis,Peter G. Pappas +64 more
TL;DR: These updated definitions of IFDs should prove applicable in clinical, diagnostic, and epidemiologic research of a broader range of patients at high-risk.
Journal ArticleDOI
Clinical Practice Guidelines for the Management of Patients with Histoplasmosis: 2007 Update by the Infectious Diseases Society of America
L. Joseph Wheat,Alison G. Freifeld,Martin B. Kleiman,John W. Baddley,John W. Baddley,David S. McKinsey,James E. Loyd,Carol A. Kauffman +7 more
TL;DR: Advances in immunosuppressive treatment for inflammatory disorders have created new questions about the approach to prevention and treatment of histoplasmosis, and new information, based on publications from the period 1999-2006, are incorporated into this guideline document.
Journal ArticleDOI
Defining Responses to Therapy and Study Outcomes in Clinical Trials of Invasive Fungal Diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer Consensus Criteria
Brahm H. Segal,Raoul Herbrecht,David A. Stevens,David A. Stevens,Luis Ostrosky-Zeichner,Jack D. Sobel,Claudio Viscoli,Thomas J. Walsh,Johan Maertens,Thomas F. Patterson,John R. Perfect,Bertrand Dupont,John R. Wingard,Thierry Calandra,Carol A. Kauffman,John R. Graybill,Lindsey R. Baden,Peter G. Pappas,John E. Bennett,Dimitrios P. Kontoyiannis,Catherine Cordonnier,Maria Anna Viviani,Jacques Bille,Nikolaos G. Almyroudis,L. Joseph Wheat,Wolfgang Graninger,Eric J. Bow,Steven M. Holland,Bart Jan Kullberg,William E. Dismukes,Ben E. De Pauw +30 more
TL;DR: An expert international panel consisting of the Mycoses Study Group and the European Organization for Research and Treatment of Cancer was convened to propose guidelines for assessing treatment responses in clinical trials of IFDs and for defining study outcomes.
Journal ArticleDOI
A Multicenter Evaluation of Tests for Diagnosis of Histoplasmosis
Chadi A. Hage,Chadi A. Hage,Julie A. Ribes,Nancy L. Wengenack,Larry M. Baddour,Maha Assi,David S. McKinsey,Kassem Hammoud,Daisy Alapat,N. Esther Babady,Michelle Parker,De Anna D. Fuller,Aliya Noor,Thomas E. Davis,Mark Rodgers,Patricia Connolly,Boutros El Haddad,L. Joseph Wheat +17 more
TL;DR: The sensitivity for detection of antigenemia is similar to that for antigenuria in disseminated infection, and is higher in immunocompromised patients than in Immunocompetent patients and in patients with more severe illness.
Journal ArticleDOI
Diabetic foot infections. Bacteriologic analysis.
L. Joseph Wheat,Stephen D. Allen,Marietta Henry,Clyde B. Kernek,Jean A. Siders,Thomas Kuebler,Naomi S. Fineberg,James A. Norton +7 more
TL;DR: Broad-spectrum beta-lactam antibiotics or a combination of antibiotics active against facultatively anaerobic cocci and bacilli as well as anaerobes provide the best empirical antimicrobial coverage in diabetic patients with foot infections.